Published in Am J Cardiol on April 01, 1971
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Increases in platelet and red cell counts, blood viscosity, and arterial pressure during mild surface cooling: factors in mortality from coronary and cerebral thrombosis in winter. Br Med J (Clin Res Ed) (1984) 4.00
Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study. Circulation (2008) 3.16
Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 2.98
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet (2013) 2.74
Blood pressure reduction in "borderline" hypertensives following physical training. Can Med Assoc J (1973) 2.03
Blood pressure survey in a population of newborn infants. Br Med J (1976) 1.87
Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension (2010) 1.84
Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed) (1985) 1.58
Blood pressure in women taking oral contraceptives. Br Med J (1974) 1.54
Predicting out-of-office blood pressure level using repeated measurements in the clinic: an observational cohort study. J Hypertens (2014) 1.53
Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension (2013) 1.50
Longitudinal survey of ischaemic heart disease in randomly selected sample of older population. Br Heart J (1977) 1.37
Risk factors for premature death in middle aged men. Br Med J (Clin Res Ed) (1984) 1.33
A prospective study of hypertension and risk of uterine leiomyomata. Am J Epidemiol (2005) 1.23
Screening for hypertension: a hospital-based home-vising programme. Br Med J (1979) 1.22
Oxidative stress contributes to the augmented exercise pressor reflex in peripheral arterial disease patients. J Physiol (2012) 1.20
Pattern of Blood Pressure Indices among the Residents of a Rural Community in South East Nigeria. Int J Hypertens (2011) 1.17
Systolic and diastolic blood pressures as predictors of coronary heart disease in middle aged Norwegian men. Br Med J (Clin Res Ed) (1987) 1.12
Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci U S A (1977) 1.06
Radionuclide measurements of diastolic function for assessing early left ventricular abnormalities in the hypertensive patient. Br Heart J (1988) 1.06
Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations. Am J Hum Genet (2014) 1.06
Is exercise good for high blood pressure? Br Med J (Clin Res Ed) (1982) 1.04
Hypertension: reflections on risks and prognostication. Med Clin North Am (2009) 1.00
Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J Clin Invest (1996) 0.99
Screening for hypertension. Br Med J (Clin Res Ed) (1983) 0.97
Effect of nitroglycerin on peripheral large arteries in hypertension. Br J Clin Pharmacol (1982) 0.92
Informativeness of indices of blood pressure, obesity and serum lipids in relation to ischaemic heart disease mortality: the HUNT-II study. Eur J Epidemiol (2011) 0.90
Screening programs for hypertension. Can Med Assoc J (1974) 0.89
Ambulatory hypertension subtypes and 24-hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation (2014) 0.88
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens (2012) 0.86
Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach. Stat Med (2014) 0.86
Stroke and coronary heart disease: predictive power of standard risk factors into old age--long-term cumulative risk study among men in Gothenburg, Sweden. Eur Heart J (2013) 0.84
Prevalence and Trends of Isolated Systolic Hypertension among Korean Adults: the Korea National Health and Nutrition Examination Survey, 1998-2012. Korean Circ J (2015) 0.83
Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol (2015) 0.83
Sudden unexpected cardiac death as a function of time since the detection of electrocardiographic and clinical risk factors in apparently healthy men: the Manitoba Follow-Up Study, 1948 to 2004. Can J Cardiol (2006) 0.83
Prediction of coronary artery disease risk based on multiple longitudinal biomarkers. Stat Med (2015) 0.82
Nitric oxide and geriatrics: Implications in diagnostics and treatment of the elderly. J Geriatr Cardiol (2011) 0.82
Arterial compliance and blood pressure. Drugs (1993) 0.82
Blood pressure characteristics of a select group of North American males, followed for 20 years. Can Med Assoc J (1972) 0.80
Interrelationship of hypertension, plasma lipids and atherosclerosis. Drugs (1988) 0.80
Control of hypertension in out-patients. Experience of the Glasgow Blood Pressure Clinic. Postgrad Med J (1980) 0.80
Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. J Am Coll Cardiol (2016) 0.80
The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target. Vasc Health Risk Manag (2008) 0.79
Multivariate prediction of total and cardiovascular mortality in an obese Polynesian population. Am J Public Health (1989) 0.78
Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome. Metabolism (2013) 0.78
Treating blood pressure to prevent strokes: The age factor. World J Cardiol (2013) 0.78
Nontraditional problems of antihypertensive management. West J Med (1979) 0.78
Expedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension. Can J Cardiol (2007) 0.78
Hypertension. Postgrad Med J (1991) 0.78
Yearlong physical activity and regional stiffness of arteries in older adults: the Nakanojo Study. Eur J Appl Physiol (2010) 0.77
Level of blood pressure control among hypertensive patients on follow-up in a regional referral hospital in Central Kenya. Pan Afr Med J (2014) 0.77
"A heart for Vienna"--the prevention program for the big city. Blue-collar workers as a special target group. Wien Med Wochenschr (2006) 0.77
Results of a 14-Week, Multicenter, Prospective, Randomized, Open-Label, Noninferiority Clinical Trial Comparing the Antihypertensive Effect and Edema Incidence of Lacidipine and Amlodipine in Older Korean Patients with Mild-to-Moderate Hypertension. Curr Ther Res Clin Exp (2013) 0.76
Is it a new approach for treating senile hypertension with kidney-tonifying chinese herbal formula? A systematic review of randomized controlled trials. Evid Based Complement Alternat Med (2014) 0.76
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination. Integr Blood Press Control (2010) 0.76
The dilemma of isolated systolic hypertension. CMAJ (1987) 0.75
Autonomy support and diastolic blood pressure: Long term effects and conflict navigation in romantic relationships. Motiv Emot (2015) 0.75
The TRINITY Study: distribution of systolic blood pressure reductions. Integr Blood Press Control (2013) 0.75
Blood pressure in the elderly. J R Coll Gen Pract (1976) 0.75
Discovering pure gene-environment interactions in blood pressure genome-wide association studies data: a two-step approach incorporating new statistics. BMC Proc (2014) 0.75
Hypertension in the elderly. Can Fam Physician (1981) 0.75
An approach to realistic evaluation of antihypertensive regimes. Postgrad Med J (1977) 0.75
Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension. Br J Clin Pharmacol (1989) 0.75
Sex- and age-related differences in arterial pressure and albuminuria in mice. Biol Sex Differ (2016) 0.75
Hypertension in the elderly: Are we all on the same wavelength? World J Cardiol (2011) 0.75
Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension. J Hum Hypertens (2015) 0.75
Identification of Normal Blood Pressure in Different Age Group. Medicine (Baltimore) (2016) 0.75
De-stiffening drug therapy and blood pressure control. Integr Blood Press Control (2010) 0.75
Screening for hypertension in general practice with an automatic machine. Br Med J (Clin Res Ed) (1984) 0.75
Hypertension and oral contraceptives. Br Med J (1978) 0.75
Mild Hypertension: Should it be Treated? Can Fam Physician (1985) 0.75
Use and abuse of antihypertensive drugs in the aged. Bull N Y Acad Med (1980) 0.75
ACE inhibition and brachial artery haemodynamics in hypertension. Br J Clin Pharmacol (1984) 0.75
High normotension is associated with future metabolic syndrome but not cardiovascular disease: A 10-year longitudinal study. Medicine (Baltimore) (2017) 0.75
Felodipine monotherapy in systolic hypertension in the elderly. Drugs (1987) 0.75
Epidemiological and demographic considerations. Hypertension in underdeveloped countries. Drugs (1986) 0.75
Effects of improved fat content of frankfurters and pâtés on lipid and lipoprotein profile of volunteers at increased cardiovascular risk: a placebo-controlled study. Eur J Nutr (2013) 0.75
Hypertension. A major public health problem in Brazil. Drugs (1988) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet (1983) 3.24
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer (2001) 3.23
The recent decrease in CHD mortality. Prev Med (1975) 3.16
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet (1974) 2.81
Labile hypertension: a faulty concept? The Framingham study. Circulation (1980) 2.76
Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74
Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71
Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr (1996) 2.70
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet (1977) 2.66
Menopause and coronary heart disease. The Framingham Study. Ann Intern Med (1978) 2.62
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med (1988) 2.62
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA (1988) 2.59
The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol (1997) 2.58
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J (1986) 2.55
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis (1974) 2.48
Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA (1972) 2.48
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47
The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors. Am J Epidemiol (1978) 2.47
The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA (1991) 2.44
Brief electrical stimulation promotes the speed and accuracy of motor axonal regeneration. J Neurosci (2000) 2.43
Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med (1981) 2.42
Cancer incidence by levels of cholesterol. JAMA (1981) 2.42
Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol (1988) 2.32